B
Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
Price:
23.92
HKD
10.23%
Market Closed
Market Cap:
HK$4.8B
Relative Value
The Relative Value of one Beijing Luzhu Biotechnology Co Ltd stock under the Base Case scenario is 34.04 HKD. Compared to the current market price of 23.92 HKD, Beijing Luzhu Biotechnology Co Ltd is Undervalued by 30%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
34.04
HKD
Undervaluation 30%
B
Multiples Across Competitors
Competitors Multiples
Beijing Luzhu Biotechnology Co Ltd Competitors
Beijing Luzhu Biotechnology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
B
|
Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
|
4.8B HKD | 0 | -31.4 | -29.5 | -29.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
386.2B USD | 6.5 | 164.5 | 16 | 22.7 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.7B USD | 5.5 | 28.1 | 19.9 | 19.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.2B USD | 6.4 | 22.8 | 15.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.4B USD | 9.9 | 31.7 | 23.2 | 24.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.9B USD | 5.6 | 18 | 15.2 | 17.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
87.9B AUD | 3.9 | 20.3 | 13.6 | 17 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 14.5 | 34 | 58.1 | 59.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
